南模生物: 首次公开发行限售股上市流通公告

Core Viewpoint - The announcement details the upcoming release of 28,575,000 restricted shares of Shanghai Nanfang Model Biology Technology Co., Ltd. for public trading, effective June 30, 2025, following the expiration of the lock-up period [1][2]. Group 1: Stock Listing Details - The total number of shares to be listed is 28,575,000, representing 36.65% of the company's total share capital [2][11]. - The shares are part of the initial public offering (IPO) and were originally subject to a 36-month lock-up period, which has been extended by 6 months due to specific conditions [2][3]. - The new trading date is set for June 30, 2025, as June 28, 2025, is a non-trading day [1][2]. Group 2: Shareholder Commitments - The controlling shareholder, Shanghai Dishi Enterprise Management Consulting Co., Ltd., has made commitments regarding the lock-up and reduction of shareholdings, including a promise not to transfer shares for 36 months post-IPO [3][5]. - If the stock price falls below the IPO price for 20 consecutive trading days within the first 6 months, the lock-up period will automatically extend for at least another 6 months [3][7]. - Other shareholders, including Shanghai Puyu Enterprise Management Consulting Partnership and Shanghai Dajun Enterprise Management Consulting Partnership, have made similar commitments regarding their shares [6][7]. Group 3: Regulatory Compliance - The underwriting institution, Guotai Junan Securities Co., Ltd., has confirmed that the release of restricted shares complies with relevant laws and regulations, ensuring accurate and complete disclosure of information [10]. - The company has not experienced any changes in share capital due to profit distribution or other factors since the formation of the restricted shares [2][10]. Group 4: Current Shareholder Status - As of the announcement date, all shareholders have adhered to their commitments, and there are no outstanding issues affecting the release of the restricted shares [9]. - There are no instances of fund occupation by the controlling shareholder or related parties [9].